HLIC HLS425562 - 100" Flow Controller Straight Set , 40 Per/Bx
Universal Spike, Roller Clamp, Spin Connector, with Hanger. Priming Volume:18 mL, Length: 40 in (101.6 cm)
Extend your IV therapy without overextending yourself!
IV Administration Set (Secondary)
Features
- Universal Spike.
- Roller clamp.
- Slide Clamp.
- Spin connector.
- Hanger added.
- Priming Volume: 19.66 mL.
- Length: 100 in. (254 cm).
Roller clamp
Roller clamp equipped with a small roller that may be rolled counterclockwise to close off primary IV tubing or clockwise to open it. The roller clamp may also be manipulated to increase and decrease the flow of the IVsolution and is easily moved with the thumb, thus making it a one-handed convenience in the administration of IV therapy.
Why Universal Spike?
A vented/non-vented or "universal" spike allows an administration set to be used with all types of solution containers. The vent should be open when infusing from non-collapsible containers (glass and semi-rigid plastic) and closed when infusing from collapsible plastic containers (bags).
What is Priming volume?
The amount of fluid required to fill the entire length of the IV administration set eliminating the air in line. At the beginning of an infusion, all IV sets are primed to avoid delivering air through the line. After the IV bag is spiked with the IV administration set, the IV solution/fluid flows through the tubing to remove the air. The priming volume of IV administration sets vary by manufacturer and affected by the length of the tubing and any add-on devices. The priming volume information can be found on the packaging label of the IV administration set.
DEHP Free
Infusion Therapy Standards of Practice advise to usee administration sets free of di-ethylhexyl-phthalate (DEHP) to administer lipid-based infusates, such as IVFE or TNA. DEHP is lipophilic and is extracted into the lipid solution with commonly used polyvinyl chloride administration sets and containers. DEHP is considered a toxin, and studies have demonstrated increased DEHP levels in lipid solutions, which is especially a risk with neonatal, pediatric, and long-term home care patients (42).
